Mechanisms of cell death in general and in the nervous system in particular have received increasing attention over the past several years. Recent studies have begun to address the pathogenetic and therapeutic implications of these mechanisms vis-a-vis human disease. This review is aimed at putting the rapidly evolving vocabulary and body of knowledge regarding cell death in the perspective of neurologic disease of childhood. (J Child Neurol 1998; 13:307-312).
Get full access to this article
View all access options for this article.
References
1.
Tomei LD, Cope FO, eds: Apoptosis: The molecular basis of cell death. Curr Commun Cell Molec Biol, vol 3. Cold Spring Harbor, Cold Spring Harbor Lab Press, 1991.
2.
Stewart BW: Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst1994 ;86: 1286-1296.
3.
a. Hartsell TL , Yalowich JC, Ritke MK, et al: Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin . J Phannacol Exp Ther1995;275: 479-485.
4.
Raff MC: Social controls on cell survival and cell death. Nature1992;356:397-400.
5.
Yang J., Liu X., Bhalla K., et al: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science1997;275:1129-1132.
6.
Kluck RM, Bossy-Wetzel E., Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science1997 ;275:1132-1136.
7.
Bredesen DE: Neural apoptosis. Ann Neurol1996;38:839-851.
8.
Kane DJ, Ord T., Anton R., Bredesen DE: Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res1995;40:269-275.
9.
Kane DJ, Sarafian TA, Anton R., et al: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science1993;262:1274-1277.
10.
Albrecht H., Tschopp J., Jongeneel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF. FEBS Lett1994;351:45-48.
11.
Forrest VJ, Kang YH, McClain DE, et al: Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med1994;16: 675-684.
12.
Ratan RR, Murphy TH, Baraban JM: Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci1994;14:4385-4392.
13.
Sandstrom PA , Mannie MD, Buttke TM: Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J Leukocyte Biol1994; 55: 221-226.
14.
Fabisiak JP, Kagan VE, Ritov VB, et al: Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquatinduced apoptosis. Am J Physiol: Cell Physiol1997;41:C675-C684.
15.
Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell1993 ;74:609-619.
16.
El-Deiry WS , Tokino T., Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell1993 ;75:817-825.
17.
Strasser A. , Harris AW, Jacks T., Cory S.: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell1994;79:329-339.
18.
Barbacid M. : Nerve growth factor: A tale of two receptors . Oncogene1993;8:2033-2042.
19.
Hempstead B. , Martin-Zanca D., Kaplan DR, et al: High-affmity NGF binding requires co-expression of the trk protooncogene and the low affinity NGF receptor. Nature1991;350:678-683.
20.
Rabizadeh S. , Oh J., Zhong L-T., et al: Induction of apoptosis by the low-affinity NGF receptor. Science1993;261:345-348.
21.
Cortazzo MH , Kassis ES, Sproul KA, Schor NF: Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affmity NGF receptor. J Neurosci1996 ;16:3895-3899.
22.
Gelbard HA, Boustany R-M., Schor NF: Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. Pediatr Neurol1997;16:93-97.
23.
Loo DT, Copani A., Pike CJ, et al: Apoptosis is induced by betaamyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA1993 ;90:7951-7955.
24.
Ziv I., Melamed E., Nardi N., et al: Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett1994;170:136-140.
25.
Walkinshaw G., Waters CM: Induction of apoptosis in catecholaminergic PC 12 cells by L-DOPA. Implications for the treatment of Parkinson's disease . J Clin Invest1995;95:2458-2464.
26.
Burke JR, Enghild JJ, Martin ME, et al: Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med1996;2:347-350.
27.
Lefebre S., Burglen L., Reboullet S., et al: Identification and characterization of a spinal muscular atrophy determining gene. Cell1995;80:155-165.
28.
Roy N., Mahadevan MS, McLean M., et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell1995;80:167-178.
29.
Lane SC, Jolly RD, Schmechel DE, et al: Apoptosis as the mechanism of neurodegeneration in Batten's disease. J Neurochem1996;67:677-683.
30.
Lerner TJ, Boustany R-M., Anderson JW, et al and the International Batten Disease Consortium: Isolation of a novel gene underlying Batten disease, CLN3. Cell1995;82:949-957.
31.
Kunimoto M. : Methyl mercury induces apoptosis of rat cerebellar neurons in primary culture. Biochem Biophys Res Commun1994;2049:310-317.
32.
Gelbard HA, James H., Sharer L., et al: Apoptotic neurons in brains of pediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol1995;21:208-217.
33.
Weller RO, Swash M., McLellan DL, Scholtz CL: Clinical Neuropathology. New York, Springer-Verlag, 1983, pp 146-147.
34.
Ahmadieh H. , Sajjadi SH, Azarmina M., Kalani H.: Association of herpetic encephalitis with acute retinal necrosis syndrome. Ann Ophthalmol1991;23:215-219.
35.
Degirolami U., Crowell RM, Marcoux FW: Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropathol Exp Neurol1984;43:57-71.
36.
Garcia JH, Chen H., Li Y., et al: Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol1993;142:623-635.
37.
Goto K., Ishige A., Sekiguchi K., et al: Effects of cycloheximide on delayed neuronal death in rat hippocampus . Brain Res1990;534:299-302.
38.
Kihara S., Shiraishi T., Nakagawa S., et al: Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci Lett1994; 175:133-136.
39.
Gwag BJ, Lobner D., Koh J., et al: Blockade of glutamate receptors during oxygen or glucose deprivation unmasks apoptosis in cultured cortical neurons. Soc Neurosci Abst1994;24:248.
40.
Wasterlain C., Thompson KW: Status epilepticus causes delayed neuronal death with DNA fragmentation in the immature hippocampus, abstract . Neurol1997;48:A391.
41.
Linnik MD, Zobrist RH, Hatfield MD: Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke1993;24:2002-2009.
42.
Crumrine RC , Thomas AL, Morgan PF: Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab1994;14:887-891.
43.
Oren M.: The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev1992;11: 141-148.
44.
Savill J.: Apoptosis in disease. Eur J Clin Invest1994 ;24:715-723.
45.
Sachs L., Lotem J.: Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood1993;82:15-21.
46.
Dole M., Nunez G., Merchant AK, et al: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma . Cancer Res1994;54: 3253-3259.
47.
Tyurina YY, Tyurin VA, Carta G., et al: Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells. Arch Biochem Biophys1997;344:413-423.
48.
Cortazzo M. , Schor NF: Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2. Cancer Res1996 ;56:1109-1203.
49.
Cortazzo MH , Kassis ES, Sproul KA, Schor NF: Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor. J Neurosci1996;16:3895-3899.
50.
LeSauteur L. , Wei L., Gibbs BF, Saragovi HU: Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses . J Biol Chem1995;270:6564-6569.
